Bausch Health Companies Inc (BHC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BHC Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Bausch Health Companies Inc Stock (BHC) Company Profile

Bausch Health Companies Inc

Healthcare (1163)

514-744-6792

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Prossima data di guadagno

Ultimi documenti SEC

BHC's Discussions on Twitter

Confronta BHC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BHC Bausch Health Companies Inc	6.31	2.37B	9.47B	-178.00M	1.01B	-0.48
ZTS Zoetis Inc	148.60	68.99B	9.29B	2.52B	2.28B	5.57
TAK Takeda Pharmaceutical Co Adr	14.43	46.36B	30.08B	710.16M	4.45B	0.2182
HLN Haleon Plc Adr	9.60	44.74B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	16.06	18.81B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	292.01	13.33B	2.99B	1.21B	1.13B	25.06

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-02	Downgrade	Piper Sandler	Neutral → Underweight
2024-07-10	Iniziato	Raymond James	Mkt Perform
2023-09-20	Aggiornamento	Jefferies	Hold → Buy
2023-06-16	Downgrade	TD Cowen	Outperform → Market Perform
2022-07-29	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-07-29	Downgrade	Truist	Buy → Hold
2022-07-28	Downgrade	JP Morgan	Overweight → Neutral
2022-06-13	Ripresa	JP Morgan	Overweight
2021-03-24	Downgrade	BofA Securities	Neutral → Underperform
2021-02-17	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2021-01-22	Downgrade	Piper Sandler	Overweight → Neutral
2020-09-17	Aggiornamento	BofA Securities	Underperform → Neutral
2020-08-24	Reiterato	H.C. Wainwright	Buy
2020-06-17	Reiterato	H.C. Wainwright	Buy
2020-04-24	Iniziato	Citigroup	Buy
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-01-22	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2019-12-12	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-02	Iniziato	Goldman	Neutral
2019-10-25	Iniziato	Cowen	Outperform
2019-09-12	Iniziato	Guggenheim	Buy
2019-08-15	Aggiornamento	TD Securities	Hold → Buy
2019-07-19	Iniziato	Wolfe Research	Outperform
2019-06-11	Ripresa	Barclays	Overweight
2019-05-13	Aggiornamento	JP Morgan	Underweight → Neutral
2019-03-20	Iniziato	SunTrust	Buy
2019-01-02	Aggiornamento	Piper Jaffray	Neutral → Overweight
2018-11-05	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2018-09-13	Aggiornamento	Piper Jaffray	Underweight → Neutral

Mostra tutto

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

Bausch Health Companies Inc Azioni (BHC) Dati Finanziari

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc Stock (BHC) Company Profile

Confronta BHC con altri titoli

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

What analysts say about Bausch Health Companies Inc. stockFree Investment Timing Strategies - Jammu Links News

What drives Bausch Health Companies Inc. stock priceRemarkable growth - Jammu Links News

Is Bausch Health Companies Inc. a good long term investmentPhenomenal returns - Jammu Links News

Best Stock to Buy Right Now: Bausch Health vs Canopy Growth? - The Motley Fool Canada

Bausch Health Faces Patent Drama And Policy Questions This Quarter - Finimize

Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says - MarketScreener

In the Wake of Bausch Health Companies Inc.'s (NYSE:BHC) Latest US$196m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions - 富途牛牛

In the wake of Bausch Health Companies Inc.'s (NYSE:BHC) latest US$196m market cap drop, institutional owners may be forced to take severe actions - simplywall.st

Amblyopia Market Growth Expected to See Next Level with Novartis - openPR.com

Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel - Yahoo Finance

Icahn Enterprises shares rise 5.72% intraday after Bausch Health appoints new Chief Accounting Officer. - AInvest

Bausch Health's Strategic Leadership Shift: Steven Lee's Expertise Could Propel Valuation Growth Amid Transformation - AInvest

First-Ever Triple-Combination Acne Treatment CABTREO Expands Access Across Canadian Health Programs - Stock Titan

Bausch Health Names Steven Lee Chief Accounting Officer - MarketScreener

Bausch Health Appoints New Chief Accounting Officer - MarketScreener

Bausch Health Strengthens Finance Team: M&A Expert Steven Lee Takes Chief Accounting Officer Role - Stock Titan

Groundbreaking Triple-Combination Acne Treatment Expands Access Across Canadian Healthcare System - Stock Titan

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs - Yahoo Finance

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence - standard-journal.com

First FDA-Approved Drug Xifaxan Unveils Powerful Patient Stories in New Hepatic Encephalopathy Campaign - Stock Titan

SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Bausch Health Companies Reaches Analyst Target Price - Nasdaq

August 22nd Options Now Available For Bausch Health Companies (BHC) - Nasdaq

Stocks In Play: Bausch Health Companies - Barchart.com

Bausch Health to Announce Second Quarter 2025 Results on July 30 - Corsicana Daily Sun

Bausch + Lomb's Dry Eye Campaign: A Strategic Opportunity in Growing Eye Health Markets - AInvest

BHC SEC FilingsBausch Health Companies Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Bausch + Lomb Brief: Closes Upsized 675 Million Euro Senior Secured Notes Offering and Partial Credit Agreement Refinancing - MarketScreener

Fed. Circ. Revives MSN Challenge To Bausch IBS Drug Patent - Law360

Bausch + Lomb Brief: Prices Upsized Senior Secured Notes Offering - MarketScreener

GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday - Benzinga

Bausch Health ticks higher following large director stock purchase - MSN

John Paulson buying at Bausch Health Companies (BHC) - The Globe and Mail

Bausch Health Companies: Insider Confidence Fuels Undervalued Stock's Turnaround Potential - AInvest

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference - The Globe and Mail

Director buying at Bausch Health Companies (BHC) - The Globe and Mail

Bausch Health: Repricing Potential Driven By Deleveraging (NYSE:BHC) - Seeking Alpha

Bausch Health Companies Inc. (TSE:BHC) Director John Paulson Acquires 754,134 Shares - MarketBeat

Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds - MSN

LOOK: These 10 Stocks Just Stole The Show - Insider Monkey

Bausch Health (BHC) Rises After Director's $15M Share Purchase - GuruFocus

Bausch Health Companies Stock Price, Quotes and Forecasts | NYSE:BHC - Benzinga

Hedge Fund and Insider Trading News: Philippe Laffont, Warren Buffett, Bill Ackman, Farallon Capital, Bausch Health Companies Inc (BHC), MicroStrategy Inc (MSTR), and More - Insider Monkey

Rising Demand in Traveler's Diarrhea MarketTop Developments, - openPR.com

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets - The Globe and Mail

Benzodiazepine Drugs Market Trends, Growth Forecast, and Top - openPR.com

Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com

Bausch + Lomb Brief: Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com

Huntington's Disease Market Grows with Increased Genetic - openPR.com

Reconstructive Surgery Market Trends, Size & Growth Forecast - openPR.com

Bausch Health Companies Inc Azioni (BHC) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a BHC